“…Pulmonary inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), involve a complex network of cytokines and chemokines that can be differentially expressed depending on the type of disease, the state of exacerbation, or the presence or absence of a concurrent bacterial or viral infection 7, 14-20. Antibody array technology is a potentially powerful technique for pulmonary inflammatory disease research and diagnostics, as it can be used to define individual cytokine profiles for patients at different levels of disease control, and to evaluate treatment options and efficacy.…”